Incidence of Lactose Intolerance Among Self-reported Lactose Intolerant People

PHASE4CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Lactose Intolerance
Interventions
DIETARY_SUPPLEMENT

Oral consumption of milk with sequence A1-A2

Oral consumption of 300 ml of milk containing both A1 and A2 type beta casein at 8:00 a.m. on Visit 1 (after 12-hour fasting) and 300 ml of milk containing only A2 type beta casein at 8:00 a.m. on Visit 2 (after 12-hour fasting).

DIETARY_SUPPLEMENT

Oral consumption of milk with sequence A2-A1

Oral consumption of 300 ml of milk containing only A2 type beta casein at 8:00 a.m. on Visit 1 (after 12-hour fasting) and 300 ml of milk containing both A1 and A2 type beta casein at 8:00 a.m. on Visit 2 (after 12-hour fasting).

All Listed Sponsors
lead

a2 Milk Company Ltd.

INDUSTRY

NCT02878876 - Incidence of Lactose Intolerance Among Self-reported Lactose Intolerant People | Biotech Hunter | Biotech Hunter